Bio-safety assessment of nanomaterials and related products is in great need for models to be developed, that enable to analyze nanotoxicity in intricate biological systems. However, up to date, there have been few investigations on feasible approaches to assess safety and toxicity of nanoscale products reported. In this paper, a dynamical system model has been proposed and a new approach for analyzing homeostasis and evaluating potential systemic toxicity in a living biological system has been developed for nanotoxicology study. Based on the model and approach, the toxicity of 30 nm-sized Fe 3 O 4 and TiO 2 nanoparticles were investigated and explained. Experiment results verify feasibility and effectiveness of the dynamical system we proposed. It also can be adapted to a wider range of applications such as general toxicology study, pharmacokinetics, diagnosis etc.
INTRODUCTION
As a newly emerged but fast growing applied science, nanotechnology has attracted a great number of interests and therefore has vital global socioeconomic value. Numerous nanoscale products have emerged and have been engineered with widespread applications in many fields such as medicine, plastics, environmental protection, energy, electronics, and aerospace [1, 2] . However, the emergence of nanoscale products not only provides great benefits to scientific fields, but also produces potential risks to humans and the environment because of their nanosize. In the past decade, little attention has been paid to the potential toxicity of manufactured nanoscale materials in risk-related research [3] . At present, scientists have to accept the fact that it is still at the beginning in the toxicological evaluation for nanomaterials, nanomedicine/ nanopharmaceuticals. Undoubtedly, nanotoxicology, defined as "science of engineered nanodevices and nanostructures that deals with their effects in living organisms", is and will be gaining more and more attention by toxicologists. Currently, toxicity studies in vitro and in vivo have been conducted using laboratory-generated model nanoparticles and data are under accumulation [4, 5] . These traditional toxicity studies, however, are based on stationary, fragmentary and short-term observations after administration or treatment with tested nanoparticles at different dose levels. These studies neglect dynamical, systemic and long-term changes and ignore relation between these changes. Thus, the real safety and toxicity of the test material can not be evaluated completely in a living intricate biological system with these methods. Evidently, the results from these studies can not reflect the toxicity profile of the tested nanoscale products.
Dynamical system focuses on the long-term behavior of evolving systems. It originated at the end of 19th century with fundamental questions concerning about stability and evolution of the solar system [6, 7] . The most important characteristic of this system is that it emphasizes the importance of dynamic changes over long time after treatment, thinks highly of the whole system to analyze and synthesize relevant separated data, and pays attention to the relationship between the changes in the system seriously. Conclusion on safety and toxicity of the tested material is based on these systemic and dynamic evaluations. Many new discoveries indicated that dynamical system could be used to explain principles in biology and life science [8] . With rapid developing of nanotechnology and emerging of numerous nanoscale products, it become more and more convincing among increasing numbers of researchers of the importance of a system-level approach [9] . From this point of view, the dynamical system approach is promising and potentially applicable to nanotoxicology study.
In the present study, a dynamical system model for nanotoxicology study was proposed and a new approach for analyzing homeostasis and evaluating potential toxicity of tested nanoparticals in a living biological system was developed. Based on the model and approach, the toxicity of 30 nm-sized Fe 3 O 4 and TiO 2 nanoparticles were investigated. The results from the present study indicated that the proposed model and approach are feasible and efficient in evaluating the potential toxicity of nanoparticles. It also can be adapted to a wider range of applications such as general toxicology study, pharmacokinetics, diagnosis etc.
ESTABLISHMENT AND ANALYSIS OF A DYNAMICAL SYSTEM MODEL 2.1. Analyze and Synthesize all the Separated Changes at One Time Point After Treatment to Develop a Systemic Model
There are some main organs in human or animal body,such as heart, spleen, liver, lung, kidney and brain. Each organ has its own normal feature parameters under physiological condition. Any changes in the parameters in one organ at one special time point after treatment reflect the fluctuation of biological function of the organ at that time. After the tested nanomaterial is administrated into the body, it would be distributed, extensively or selectively, in various organs and induce toxic effect on the organ. Evaluation of toxicity based on only one or several single organ(s) can not reflect the whole systemic toxicity profile of the material. In view of systemic toxicity induced in the biological system, we combine all the separated feature parameters from each organ together to get a feature vector, which would be the systemic fluctuation of the whole biological system. We call it feature state (X) of the biological system. X is given by Any changes in X at one time point after treatment with the tested nanomaterial is considered to be systemic changes induced by the material at that time.
Analyze and Synthesize the Separated Changes at All Time Points After Treatment to Develop a Dynamical Model
Based on pharmacokinetic parameters such as distribution volume versus time, elimination half life, mean residence time, total clearance, the content of the administrated nanoparticles within an organ is changing dynamically over long time after treatment. As a result, it will induce significant difference in severity and pattern of toxicity in a given organ at different time point post dose. Evaluation of toxicity of the tested nanoparticle based on only one or several single time point(s) can not reflect the whole dynamical changes after X Heart Spleen Liver Lung Kidney Brain
administration. Thus, on the base of establishment of systemic changes of the whole biological system at one time point, it is necessary for us to analyze and synthesize the separated systemic changes at all time points after treatment to develop a dynamic and systemic model. From this dynamic view, we combine all the separated changes in X at all post dose time points together to set up the dynamic model. Assume x H (t), x S (t), x L (t), x U (t), x K (t) and x B (t) represent the feature parameters of Heart, Spleen, Liver, Lung, Kidney and Brain respectively. Since difference between bio-individuals, these values are determined by computing mean of repeat experiments. The equation of biological system is as follows:
a ij (t) represents the continuous changing impaction which x i (t) contributes to x j (t) due to complex fluctuations in vivo.
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factor from outside. This equation could also be rewritten as matrix representative form (1).
(1)
Here X is the state, usually can be considered as quantities of representative feature parameters. X · is state differential. M(t) represents relation matrix among each component, which is always changing due to complex fluctuations in vivo. B is impact factors from outside. The theory about matrix could be found in reference [10] . The meanings of each variable are shown below.
Take human body for example, when human body is under normal condition, M(t) is usually changing in a narrow range. B is a stimulus from outside, such as diet, environment, and pharmaceutical interventions, both beneficial and adverse, which would make human body fluctuate more intensively than normal. Usually, we expect that our intervention from outside makes human body converge to homeostasis as soon as possible. In this case, equation (1) reflects change of feature parameters (maybe representative compounds) in human body. It's easy to understand that human body always tries to keep homeostasis and system could be normally regulated to homeostasis when intervention from outside comes. B(t) factor could be got from experiments or databases in practice. However, determining matrix M(t) is the most difficult step. Appendix A shows an
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example to construct M(t) from relation graph,where A, B, C, D are organs involved, a is coefficient representing interaction between organs,which could be determined by specific experiments.
HOMEOSTASIS, EQUILIBRIUM OF SYSTEM AND TOXICITY
X, which represents feature state of system, should maintain at a definite range when biological system is under normal condition. Illness could influence biological system and result in abnormal feature state. The stability of equation 1 reflects the whole features of biological system. Pharmaceutical intervention could change system state. Illness leads system to divergence. A "good" drug should adjust all parameters to normal condition. If drug could only adjust part of related parameters to normal level and make the rest diverge, maybe we can treat it as toxicity. Toxicity here can be defined as deviation of feature states. We define homeostasis by equation. To system, Its stationary solutions is X 0 , δ is a prior parameter decided by system. To an input B of
The stationary solution of equation is X b , and If | X b − X 0 | ≤ δ, we can believe system converge to equilibrium, and B is a lossless input to system. If | X b − X 0 | > δ, we believe system is far from equilibrium, and B is a lossy input to system. Stationary solutions mean equation equilibrium, which is homeostasis in biological system.
Following the definition above, we can explain toxicity from aspect of B. Usually, drug metabolism differs much, and it is not easy to judge homeostasis, while we can judge it from Lyapunov stability.
To a certain type of input, the influence matrix M(t) is always determinate. This implies M(t) is constant or nearly constant. Lyapunov stability originated from physics. If system is stable, it exists a positive system energy function whose differential is negative, which means energy decline through time. We can define toxicity from this.
Following Lyapunov stability, we can compare the influence of stimulus from short-term with those from long-term to judge the system state.
X S means short-term state of the system; X L means long-term state of the same system.
If | X L | ≤ | X S |, we come to believe that biological system converge to homeostasis, and B is a lossless input to body.
If | X L | > | X S |, we believe that biological system is far from homeostasis, and B is a lossy input to body.
We discussed the safety judgment of drug above. In order to specify extent of its toxicity, which corresponds to its deviation extent of feature states, we use norm theory for classification.
n-norm of vector
So when n = 1, it is 1-norm, see below,
When n = ∞, it is ∞-norm, see below
Different norm implies the different measure in comparison among different time point. 1-norm is accepted as lowest standard in our theory. ∞-norm is more conservative and rigorous than others because it only compares its largest component.
When n is larger, S n (
Assuming when n = T, the equation (5) is first satisfied.
The smaller T is, the more conservative and rigorous data are, which means the safety level is higher.
we believe that biological system converge to homeostasis, and B's safety level is T.
If S n (X L ) − S n (X S ) > 0, we believe that biological system is far from homeostasis, and B's unsafety level is T.
APPLICATION OF PROPSED DYNAMICAL SYSTEM MODEL IN NANOTOXICOLOGY
In order to test the feasibility and effectiveness of the proposed dynamical system model in nanotoxicology study, tissue distribution and potential toxicity of single-and repeat-dose subcutaneous administration of Fe 3 O 4 nanoparticles (Nano-Fe 3 O 4 ) and TiO 2 nanoparticles (Nano-TiO 2 ) were evaluated in mice using this approach.
Materials and Animals

Materials
Nano-Fe 3 O 4 and Nano-TiO 2 have a mean particle diameter of 30 nm. All particle samples were prepared in 10 mM phosphate-buffered saline (PBS) solution and subjected to sonication for 15 min at 60 Hz. The solution was filtered by a sterile filter. And the respective dose of Nano-Fe 3 O 4 and NanoTiO 2 were administrated subcutaneously to the animals within 30 min after dissolution.
Animals
All animal studies were performed in accordance with regulatory guidance's on the care and use of experimental animals.
Male KM mice (17.1-22.4 g), supplied by Shanghai SLAC laboratory animal Co., Ltd, were housed in a temperature-and light-controlled room (25 ± 2°C, 40 -70% relative humidity, 12 h light/dark cycle), acclimatized in our laboratory for a period of at least 5 days before experiment, with free access to water and food.
Organ Distribution and Toxicity Study 4.2.1. Single-dose administration study
In the single-dose administration study, the mice were randomized into nanoparticles group and control group with 10 in each group. In nanoparticles group, mice fasted overnight were treated subcutaneously with nanoparticles (Nano-Fe 3 O 4 :100 mg/kg,or Nano-TiO 2 :300 mg/kg ,in a dose volume of 20 mL/kg) for investigation of acute signs of toxicity. The control mice were given equal volume of PBS as vehicle. After treatment the animals were observed continuously for the first hour, followed by every hour up to 6 h for any changes in behavior and manifestations of the toxic symptoms. All animals were sacrificed 24 hours after injection and received a complete necropsy. The iron contained in heart, spleen, liver, lung, kidney, brain was evaluated with flame atomic absorption spectrometry (FAAS) after pretreatment. The Ti contained in heart, spleen, liver, lung, kidney, spermary was evaluated with inductively coupled plasma-optical emission spectrometry (ICP-OES) after pretreatment. The pathological observation was also conducted.
Repeat-dose administration study
In the repeated dose administration study, the mice were randomized into nanoparticles group and control group. Each group consisted of 10 animals. The mice in the nanoparticles group received a single SC injection of nanoparticles at a dose of 100 mg/kg(Nano-Fe 3 O 4 ) or 300 mg/kg (Nano-TiO 2 ) once a day for 10 days (a total of ten injections). The animals of the control group received the same multiple SC injection of PBS for 10 days. All animals were examined for mortality and clinical signs daily. At the end of the observation period, the mice were sacrificed 24 hours after last injection and a complete necropsy for examining macroscopically visible changes. A small part of organ tissues were dissected and prepared for pathology, the rest were prepared for FAAS(NanoFe 3 O 4 ) or ICP-OES(Nano-TiO 2 ).
FAAS Analysis and ICP-OES Analysis
FAAS analysis
Analyses of all samples were carried out by FAAS(Varian 240) for Fe. The average recovery of iron was 93.9%, and the standard deviations were low, proving good repeatability of the method.
Sample digestion procedures used microwave digestion. For an organ sample, digestion aliquots of 0.200 g of sample were digested using 4 mL HNO 3 . Following digestion, samples were filtered and made up to 25 mL using ultra high purity water for analysis. Six organ samples were analysed for each site. With each batch of extractions, a blank of HNO 3 was analyzed at the end of each extraction step. Blank levels were found to be below detection limits in all cases.
ICP-OES analysis
The analyse of Ti was performed with ICP-OES (PerkinElmer Optima 2100 DV) by using microwave digestion techniques. The proposed method indicated satisfactory recovery, detection limits and standard deviation for trace Ti determination in tissue samples.
Results and Discussion
Single-dose administration study
The objective of this study was to investigate the acute toxic potential of nanoparticles in KM-mice following single subcutaneous injection, in order to select appropriate way of administration and dose for repeat dose studies.
Based on the results of preliminary experiments and also the reference [11] , we chose SC injection of nanoparticles at the dose level of 1/20 LD50, i.e. 100 mg/kg for Nano-Fe 3 O 4 and 300 mg/kg for Nano-TiO 2 . Upon injection, and throughout the whole study, no unusual behavior or differences between groups were observed.
In the single-dose toxicity study, there were no abnormal clinical findings in mice given a single SC injection of nanoparticles at the dose level accordingly. The treatment caused no obvious signs of abnormalities in body weight, organ weight and histopathological findings when compared to the control group.
The data (Figure 1) showed that the iron contained in Nano-Fe 3 O 4 was incorporated into the body's iron store and distributed in heart, spleen, liver, lung, kidney and brain decreasingly. It also suggested that the maximum tolerated dose of Nano-Fe 3 O 4 , when given subcutaneously, is greater than 100 mg/kg in this case. The data (Figure 2) showed that the titanium contained in Nano-TiO 2 was distributed in liver, spleen, spermary, lung, heart and kidney decreasingly. And the maximum tolerated dose of Nano-TiO 2 given subcutaneously is greater than 300 mg/kg in this case.
Repeat-dose administration study
In the repeat-dose toxicity study, nanoparticles injected at high-dose level (Nano-Fe 3 O 4 100 mg/kg, up to more than 80 times the human dose) in our experimental conditions were also well tolerated in mice, with no obvious signs of systemic toxicity or abnormalities in body weight, organ weight and histopathological findings. The data (Figure 1 ) demonstrated that iron level on each organ tissues were lower at the end of the treatment period compared with single-dose injection values. The accumulation of iron on organs studied is slight, indicating that iron is eliminated fast at the dose of 100 mg/kg given subcutaneously in mice. The data (Figure 2) showed that titanium level on each organ tissues were a little higher compared with single-dose injection. The accumulation of titanium on organs studied is greater than iron ,while still slight. 
Application of norm theory for data analysis
Although we can not model life system by rigorous formula, we can reflect its state by selecting parameters. Here we choose heart, spleen, liver, lung, kidney and brain (spermary) to be our feature parameters from experiments, we use feature vector as an index to evaluate the systemic toxic effect.
From the data ( Fig. 1 & Fig. 2 ) , Eqs. (3) and (4) ,we get the value of 1-Norm and ∞-Norm(Tab. 1 & Tab. 2).From Eqs. (2) and (5) we get (un)safety level T of two nanoparticles (Table 2) .
We can get similar result from the norm theory. It's obvious that for Fe, the repeat-dose feature of mice is less than single-dose feature, which means that after repeated injection, mice body state converges and regresses to its normal state. For Ti, the repeat-dose feature of mice is more than single-dose feature, which shows that after repeated injection, mice body state diverges and the mice body state is far from its normal state. What's more,the safety level is 76 for Nano-Fe 3 O 4 and the unsafety level is 43 for Nano-TiO 2 respectively by calculations.
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... The results of most of the studies demonstrated low hazard potential in mice following acute injection to Nano-Fe 3 O 4 and Nano-TiO 2 tested in this program.
DISCUSSION
In this paper, the dynamical system model was proposed for nanotoxicology study in vivo. Its effectiveness and robustness were preliminarily reflected by our experiment. The application of dynamical system to nanotoxicology study might have a promising future. Moreover, the significance of our work is not confined to modeling the relation of the dynamical system and the nanotoxicology study, it can be adapted to a wider range of applications. Our framework could also be used to analyze other factors such as toxicology study at general scale, pharmacokinetics, diagnosis etc.
Dynamical system enables the analysis of intricate biological systems. Although the road ahead is long, we expect the future in which biology and medicine could be described by precision model and toxicology could be precisely measured.
We could get matrix M(t) from figure 3 as follows:
Hence we build system model based M(t). Since M(t) could be constructed by method presented above, it's reasonable to believe that this M(t) is existent, which also proves that all we do now is meaningful in practice. 
